熱門資訊> 正文
Reviva Pharmaceuticals希望通过直接发行筹集300万美元;股价下跌
2024-05-28 20:45
- Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025)(RVPHW) 0
- Reviva Pharmaceuticals Holdings Inc. Ordinary Shares(RVPH) 0
- Reviva Pharmaceuticals (NASDAQ:RVPH) said it is looking to raise $3M through the sale and issuance of 1.89M shares, warrants to buy up to 1.89M shares at a combined offering price of $1.58 apiece.
- Shares in the company down 7.8% in premarket trade.
- The warrants have an exercise price of $1.455 per share, the firm said.
More on Reviva Pharmaceuticals
- Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
